show episodes
 
Did you know that your clear view of the world, the one that allows you to read, drive and recognize faces, relies on the health of your retinas? Join host Dr. Timothy Murray as he brings you inspiring conversations about your sight and the special role the retina plays in making healthy vision possible. Dr. Murray welcomes expert retina specialists to share the latest advances in retina care as well as patients to discuss living life to the fullest with retinal disease. Listen today and lea ...
 
Health Care Rounds is a weekly podcast developed for health care leaders who are at the forefront of health care delivery and payment reform. Join Darwin Research Group founder and CEO John Marchica as he discusses the latest advancements in health care business news and policy developments, including interviews with dynamic leaders in health care. John is a veteran health care strategist and is leading ongoing research initiatives on health care delivery systems and value-based care. Health ...
 
Loading …
show series
 
Kidney research, pet health, manufacturing is valuable, and a couple of biotech IPOs Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-055-1 https://tinyurl.com/Niche-055-2 https://tinyurl.com/Niche-055-3 https://tinyurl.com/Niche-055-4 https://tinyurl.com/Niche-055-5 Music by Luke Goodson https://www.soundcloud.com…
 
Dr. John Shufeldt founded NextCare Inc. in 1993 and served as the CEO and Chairman of the Board until 2010. He now serves as the business manager and one of the founding partners of Empower Emergency Physicians and continues to practice emergency medicine at St. Joseph’s Hospital and Medical Center. Dr. Shufeldt also founded MeMD, LLC, a platform u…
 
We dive deep into Alzheimer’s, Regeneron execs might be overpaid, a merger in clinical research, and the FDA issues a Class 1 recall Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-054-1 https://tinyurl.com/Niche-054-2 https://tinyurl.com/Niche-054-3 https://tinyurl.com/Niche-054-4 https://tinyurl.com/Niche-054-5 …
 
Josh Komenda is co-founder, CEO and president of healthcare logistics leader, Veyo, a full service NEMT broker using technology to better manage NEMT benefits for Medicaid and Medicare programs, state governments, and Managed Care Organizations. While focusing on the technology platform, Josh and his team recognized the need for Non-emergency Medic…
 
Pending FDA approvals, expanded FDA approvals, new FDA approvals, and a lawsuit about FDA approvals. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-053-1 https://tinyurl.com/Niche-053-2 https://tinyurl.com/Niche-053-3 https://tinyurl.com/Niche-053-4 https://tinyurl.com/Niche-053-5 https://tinyurl.com/Niche-053-6 …
 
Dr. Robert Pearl is the former CEO of The Permanente Medical Group and former president of The Mid-Atlantic Permanente Medical Group. In these roles was responsible for the nationally recognized medical care of 5 million Kaiser Permanente members on the west and east coasts. Named one of Modern Healthcare’s 50 most influential physician leaders, Pe…
 
M&A Speed Bumps, “Normal” IPO but not approach, two updates, and FDA gives nod to menstrual bleeding, prostate cancer, and COVID19 monoclonal antibodies. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-052-1 https://tinyurl.com/Niche-052-2 https://tinyurl.com/Niche-052-3a https://tinyurl.com/Niche-052-4 https://ti…
 
Spencer Hutchins is the CEO and co-founder of Concert Health, America’s leading behavioral health medical group with a turnkey solution designed for primary care and women’s health physicians. Concert Health’s exceptional team of clinicians deliver Collaborative Care Management, an evidenced-based model proven to treat anxiety, depression, and othe…
 
Retina patients have a critical role to play in maintaining their retinal health by seeking out treatment from a retina specialist, becoming informed about their condition and following through on their treatment plan. On this episode of ASRS's Retina Health for Life, Dr. J. Michael Jumper of West Coast Retina in San Francisco joins Dr. Timothy Mur…
 
Oncology on the move, an industry report looking at broader trends, good news in Alzheimer’s, and another niche oncology therapy approved. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-051-1 https://tinyurl.com/Niche-051-2 https://tinyurl.com/Niche-051-3 https://tinyurl.com/Niche-051-4 https://tinyurl.com/Niche-…
 
Dr. Emanuel has over 26 years of research and development, marketing and management experience in biotechnology projects, including development of drug delivery systems and immunology. His extensive expertise includes immunotherapy, vaccines, immunodiagnostics, systemic and local drug-delivery, and medical devices. Dr. Emanuel has a number of appro…
 
Two FDA approvals, cellulite and tattoos, Ginkgo pulls in $2.5B, and Caris massive growth equity for oncology testing. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-50-1 https://tinyurl.com/Niche-50-2 https://tinyurl.com/Niche-50-3 https://tinyurl.com/Niche-50-4 https://tinyurl.com/Niche-50-5 https://tinyurl.com…
 
Christopher Robertson joined the Boston University law school faculty in 2020 as a tenured professor and an N. Neal Pike Scholar in health and disability law. Prior to that, he served as associate dean for research and innovation and professor of law at the University of Arizona. He is also a principal at Hugo Analytics, a firm that provides scient…
 
Critical intellectual property move by Biden-Harris, Pfizer goes for full approval, SPAC 1, SPAC 2, Regeneron drops big numbers, and an IPO gets punted. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-049-1 https://tinyurl.com/Niche-049-2 https://tinyurl.com/Niche-049-3 https://tinyurl.com/Niche-049-4 https://tiny…
 
Did you know that your clear view of the world, the one that allows you to read, drive and recognize faces, relies on the health of your retinas? On this episode of ASRS’s Retina Health for Life, retina specialist Dr. Ryan Rich of Retina Consultants of Southern Colorado joins Dr. Timothy Murray to discuss what the retina is, how they make healthy v…
 
Karthik Ganesh is the CEO of EmpiRx Health, the industry’s only value-based PBM, with a clinically focused, technology-enabled approach to bending the Rx cost curve. Prior to EmpiRx Health, Karthik was the founding operations leader of CareAllies. He is a senior health care executive with a solid track record of comprehensively scaling, transformin…
 
Welcome to a monthly bonus episode. I sat down with Dr. Amir Kalali, the co-chair of the Decentralized Trials & Research Alliance (DTRA) – a clinical research coalition of the most influential companies in the field to talk about decentralized research and collaborating for our success as an industry. 2:35 – From CRO to CNS Summit 10:30 – Ramping u…
 
The FDA slaps wrists and takes names, Farxiga expands FDA approval, BioVie makes cash-light acquisition, Pfizer targets fungus, and one IPO down, another to go. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-047-1 https://tinyurl.com/Niche-047-2 https://tinyurl.com/Niche-047-3 https://tinyurl.com/Niche-047-4 http…
 
Dr. Thomas Young is a board-certified family physician with more than 35 years of medical experience. He is recognized as an innovator and thought leader in the fields of consumer-directed health care and population health care management. Dr. Young is the founder and chief medical officer of nView Health, an innovative software company that helps …
 
Billion-dollar amendments, billion-dollar funds, GSK gets oncology nod from FDA, and two stories in clinical research. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-046-1 https://tinyurl.com/Niche-046-2 https://tinyurl.com/Niche-046-3 https://tinyurl.com/Niche-046-4 https://tinyurl.com/Niche-046-5 Music by Luke …
 
Dr. Hale is the chief medical officer at VirtuSense Technologies, a health care company that uses proprietary technology and artificial intelligence to reduce adverse events within hospitals, skilled nursing facilities, and senior living communities. He previously was the senior vice president for care solutions at Navvis Healthcare, after a 37-yea…
 
Retinopathy of prematurity is a retinal condition that can affect premature infants, and is the most common cause of vision loss in children. On this episode of ASRS's Retina Health for Life, Dr. R.V. Paul Chan of the Illinois Eye and Ear Infirmary at the University of Illinois at Chicago joins Dr. Timothy Murray to discuss why screening premature …
 
Massive acquisitions in the CRO space, Trodelvy 2x, diagnostic acquisitions, Merck closes COVID vaccine program, Xolair get’s self-injection nod, and tiny robots go for massive SPAC. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-045-1 https://tinyurl.com/Niche-045-2 https://tinyurl.com/Niche-045-3 https://tinyur…
 
Sean Brusky, health care entrepreneur, executive advisor, strategist, and former head of health care delivery innovation at Genentech/Roche Sean’s career has developed around a central theme: How can we innovate to help Pharma become true partners in value-based care? Over the course of 15 years in various leadership roles with Genentech/Roche, Sea…
 
Gilead gets FDA approval in oncology, Bio-Techne acquires Asuragen, AI for tumor targeting, and Achilles completes $175M IPO. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-044-1 https://tinyurl.com/Niche-044-2 https://tinyurl.com/Niche-044-3 https://tinyurl.com/Niche-044-4 Music by Luke Goodson https://www.sound…
 
Paul VerHoeve is CEO and a board member for Mission Healthcare. With more than 20 years of health care leadership experience, he has been recognized as a driver of healthy workplace culture. Prior to his involvement with Mission Healthcare, Paul was president of the west region with Louisville, Ky.-based Kindred Healthcare, one of the largest post-…
 
Charles River acquires Retrogenix, IQVIA fully acquires Q2 Solutions, Agios sells $1.8B in oncology, and Alloy forges a $75M series C. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-043-1 https://tinyurl.com/Niche-043-2 https://tinyurl.com/Niche-043-3 https://tinyurl.com/Niche-043-4 https://tinyurl.com/Niche-043-…
 
Dr. Kyle Guyton is a pediatrician, CFO and co-founder of SouthernMED Pediatrics, a multi-site pediatric and counseling practice with 10 locations throughout South Carolina. In addition to caring for his patients, he serves his local community as a member of the Lexington County School District One School Board. Dr. Guyton attended the Medical Unive…
 
This is our March bonus episode. I sit down with Dr. Benjamin Schwartz an orthopedic surgeon and digital health expert. We talk digital integration, healthcare cost, and how you can get involved in the space. Sponsors https://www.thescopemethod.com Guest References https://www.benschwartzmd.com/ https://www.linkedin.com/in/ben-schwartz-md/ Music by…
 
Mergers in precision oncology testing, Medtronic breakthrough valve replacement, Gyroscope raises capital for AMD, and small molecule genetic treatments get $240M IPO. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-041-1 https://tinyurl.com/Niche-041-2 https://tinyurl.com/Niche-041-3 https://tinyurl.com/Niche-041…
 
Daniel J. Durand, M.D. serves as the chief innovation officer and chairman of radiology for LifeBridge Health. He led the LifeBridge Health ACO, LLC, and previously served as the first director of accountable care for Johns Hopkins Medicine. Prior to Hopkins, Dr. Durand was a vice president and member of the executive leadership team at Evolent Hea…
 
Uveal melanoma, or ocular melanoma, is the most common eye cancer diagnosed in adults, affecting approximately 2,500 people in the United States each year. Unrelated to skin melanoma, uveal melanomas often have no signs or symptoms, underscoring the importance of regular dilated retina exams for early diagnosis and treatment to safeguard sight. On …
 
A new MS therapeutic, Fujifilm picks CDMO facility site, consolidation in medical services, and a new oncology startup. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-040-1 https://tinyurl.com/Niche-040-2 https://tinyurl.com/Niche-040-3 https://tinyurl.com/Niche-040-4 Music by Luke Goodson https://www.soundcloud.…
 
Dr. Anthony Orsini is a practicing physician, author and frequent speaker on the topic of compassionate communication in medicine. He is a Level II Medical Director at one of the largest Neonatal Intensive Care Units in the world. He also serves as Chief of Patient Experience and Palliative Care Liaison for his neonatal practice, and is a frequent …
 
Retinoblastoma is a rare form of eye cancer that affects infants and young children. In recent years, significant advances have been made in retinoblastoma diagnosis and treatment, helping not only save children's lives but in many cases preserving vision in the eye affected by cancer. On this episode of ASRS’s Retina Health for Life, Dr. Carol Shi…
 
92% reduction in COVID mortality, AVEO gets FDA approval, Takeda acquires Maverick and targets emerging markets, and AgomAb raises $74M Series B for regenerative medicine. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-039-1 https://tinyurl.com/Niche-039-2 https://tinyurl.com/Niche-039-3 https://tinyurl.com/Niche…
 
Jon Warner, CEO and Board Chair Decision-support Architect for Innovation, Technology, DigitalHealth, Aging populations Five-time company CEO Jon Warner is a widely respected entrepreneurship expert. His career started in the corporate world with Air Products, working in the US and across Europe before joining Exxon-Mobil. At Exxon, Jon worked in t…
 
Amgen nabs Five Prime Therapeutics in $1.9B deal, KemPharm ligates their way out of debt with ADHD, three failed COVID19 pipelines, and Colfax follows 2019 merger with corporate split. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/niche-038-1 https://tinyurl.com/niche-038-2 https://tinyurl.com/niche-038-3 https://tiny…
 
2:07 - 2:13 Scott: “It was originally sort of a hobby and a marketing effort to develop a brand in health care.” 16:22 - 16:25 Scott: “So I understood the niche marketing concept, being in a niche within health care.” 19:10 - 19:18 Scott: “It wasn’t until 7-8 years ago when we started, you know, really thinking about this as a serious business, whe…
 
I sit down with Dr. Mitrani, the Chief Scientific Officer for Organicell, a clinical stage biopharma company focused on regenerative medicine. Their leading product, Zofin is currently in early clinical trials for the treatment of COVID19. Eventually it may be a therapeutic for long haulers. Key Talking Points 2:43 - Dr. Mitrani’s Journey to regene…
 
PRA acquired by Icon, Johnson & Johnson’s vaccine approved, Oncopeptides’ earns FDA approval, Roivant acquires Silicone Therapeutics, and Merck acquires Pandion. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/niche-036-1 https://tinyurl.com/niche-036-2 https://tinyurl.com/niche-036-3 https://tinyurl.com/niche-036-4 htt…
 
Treatments for some retinal conditions like age-related macular degeneration (AMD) require frequent appointments, which can be a burden for both patients and their families. On this episode of ASRS’s Retina Health for Life, Dr. Jeffrey Heier of Ophthalmic Consultants of Boston joins Dr. Timothy Murray to discuss the treatment burden that many patie…
 
Kevin Hrusovsky, Precision Health Visionary, Chairman & CEO, Quanterix Kevin Hrusovsky is a biotech entrepreneur and healthcare visionary who has dedicated his career to transforming medicine into preventative and personalized healthcare. Hrusovsky currently serves as the President, Chairman and CEO of Quanterix, a company digitizing biomarker anal…
 
Advanced imaging technologies have enhanced retina specialists’ ability to diagnose, manage and treat many retinal conditions including age-related macular degeneration (AMD). On this episode of ASRS’s Retina Health for Life, Dr. Justis Ehlers of the Cole Eye Institute at the Cleveland Clinic joins Dr. Timothy Murray to discuss these new imaging te…
 
Eli Lilly bets on RIPK1, Charles River spends $875M on cell and gene therapy, Adjuvant Capital gets who’s who in backing, you can now buy an at-home COVID19 testing kit whenever you want, and Abbott does it again for the 389th time. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/niche-35-1 https://tinyurl.com/niche-35-…
 
Advances made in the treatment of wet age-related macular degeneration (AMD) in the last two decades are among the most exciting in all of medicine. On this episode of ASRS’s Retina Health for Life, Dr. Peter Kaiser of the Cole Eye Institute at the Cleveland Clinic joins Dr. Timothy Murray to discuss #AMD treatments on the horizon that may lead to …
 
Genentech’s next tech, GSK divests to invest, Bristol Myers Squibb checks oncology, Cassava Sciences raises capital, Libtayo gets expanded FDA approval, and Hyperfine turns on hyperdrive. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-34-1 https://tinyurl.com/Niche-34-2 https://tinyurl.com/Niche-34-3 https://tiny…
 
Age-related macular degeneration (AMD) affects 11 million Americans, but with early diagnosis and treatment by a retina specialist, vision loss from the wet form of AMD can be avoided. On this episode of ASRS’s Retina Health for Life, ASRS President Dr. Carl Awh of Tennessee Retina joins Dr. Timothy Murray to discuss all things #AMD including imagi…
 
Two Mercks - three stories, Paraxel gets genomes, Genomes get Money, and 2021 is the year of the upsized public offering. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-33-Merck1 https://tinyurl.com/Niche-33-Merck2 https://tinyurl.com/Niche-33-Merck3 https://tinyurl.com/Niche-33-2 https://tinyurl.com/Niche-33-3 h…
 
Biogen gets punted but it’s good, lupus breakthroughs, Senseonics raises capital, and Novavax and Johnson & Johnson… and Janssen. Sponsors https://www.thescopemethod.com Story References https://tinyurl.com/Niche-032-1 https://tinyurl.com/Niche-032-2 https://tinyurl.com/Niche-032-3 https://tinyurl.com/Niche-032-4 https://tinyurl.com/Niche-032-5 Mus…
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login